While injection site discomfort is typically minimal and transient, GLP-1 receptor agonists are associated with several systemic side effects that patients should understand
The evidence base for GLP-1 agonists in binge eating disorder remains preliminary, with most data coming from case reports, small case series, and secondary analyses rather than large randomized controlled trials specifically designed for BED
L - Carnitine is also involved in building muscle mass
Some individuals may utilize GLP-1 (glucagon-like peptide-1) drugs, sometimes called GLP-1 receptor agonists, to help them decrease weight
That said, here's what to know: Common (mild): Injection site redness or irritation
Veterinary use has included applications in racing horses, companion animals, and other species